Report Overview
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Human Immune Globulin Intravenous market size was estimated at USD 13360 million in 2023 and is projected to reach USD 24769.18 million by 2032, exhibiting a CAGR of 7.10% during the forecast period.
North America Human Immune Globulin Intravenous market size was estimated at USD 3917.84 million in 2023, at a CAGR of 6.09% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Human Immune Globulin Intravenous market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Immune Globulin Intravenous Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Immune Globulin Intravenous market in any manner.
Global Human Immune Globulin Intravenous Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market Segmentation (by Type)
IVIg Liquid
IVIg Powder
Market Segmentation (by Application)
Immunodeficiency
Autoimmune Disease
Acute Infection
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Human Immune Globulin Intravenous Market
� Overview of the regional outlook of the Human Immune Globulin Intravenous Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Immune Globulin Intravenous Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Immune Globulin Intravenous, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Immune Globulin Intravenous
1.2 Key Market Segments
1.2.1 Human Immune Globulin Intravenous Segment by Type
1.2.2 Human Immune Globulin Intravenous Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Immune Globulin Intravenous Market Overview
2.1 Global Market Overview
2.1.1 Global Human Immune Globulin Intravenous Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Immune Globulin Intravenous Market Competitive Landscape
3.1 Global Human Immune Globulin Intravenous Sales by Manufacturers (2019-2025)
3.2 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2019-2025)
3.3 Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Immune Globulin Intravenous Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Human Immune Globulin Intravenous Sales Sites, Area Served, Product Type
3.6 Human Immune Globulin Intravenous Market Competitive Situation and Trends
3.6.1 Human Immune Globulin Intravenous Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Immune Globulin Intravenous Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Immune Globulin Intravenous Industry Chain Analysis
4.1 Human Immune Globulin Intravenous Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Immune Globulin Intravenous Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Immune Globulin Intravenous Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Immune Globulin Intravenous Sales Market Share by Type (2019-2025)
6.3 Global Human Immune Globulin Intravenous Market Size Market Share by Type (2019-2025)
6.4 Global Human Immune Globulin Intravenous Price by Type (2019-2025)
7 Human Immune Globulin Intravenous Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Immune Globulin Intravenous Market Sales by Application (2019-2025)
7.3 Global Human Immune Globulin Intravenous Market Size (M USD) by Application (2019-2025)
7.4 Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2025)
8 Human Immune Globulin Intravenous Market Consumption by Region
8.1 Global Human Immune Globulin Intravenous Sales by Region
8.1.1 Global Human Immune Globulin Intravenous Sales by Region
8.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Region
8.2 North America
8.2.1 North America Human Immune Globulin Intravenous Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Immune Globulin Intravenous Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Immune Globulin Intravenous Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Immune Globulin Intravenous Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Immune Globulin Intravenous Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Human Immune Globulin Intravenous Market Production by Region
9.1 Global Production of Human Immune Globulin Intravenous by Region (2019-2025)
9.2 Global Human Immune Globulin Intravenous Revenue Market Share by Region (2019-2025)
9.3 Global Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Human Immune Globulin Intravenous Production
9.4.1 North America Human Immune Globulin Intravenous Production Growth Rate (2019-2025)
9.4.2 North America Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Human Immune Globulin Intravenous Production
9.5.1 Europe Human Immune Globulin Intravenous Production Growth Rate (2019-2025)
9.5.2 Europe Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Human Immune Globulin Intravenous Production (2019-2025)
9.6.1 Japan Human Immune Globulin Intravenous Production Growth Rate (2019-2025)
9.6.2 Japan Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Human Immune Globulin Intravenous Production (2019-2025)
9.7.1 China Human Immune Globulin Intravenous Production Growth Rate (2019-2025)
9.7.2 China Human Immune Globulin Intravenous Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Takeda
10.1.1 Takeda Human Immune Globulin Intravenous Basic Information
10.1.2 Takeda Human Immune Globulin Intravenous Product Overview
10.1.3 Takeda Human Immune Globulin Intravenous Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda Human Immune Globulin Intravenous SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 Grifols
10.2.1 Grifols Human Immune Globulin Intravenous Basic Information
10.2.2 Grifols Human Immune Globulin Intravenous Product Overview
10.2.3 Grifols Human Immune Globulin Intravenous Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols Human Immune Globulin Intravenous SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 CSL
10.3.1 CSL Human Immune Globulin Intravenous Basic Information
10.3.2 CSL Human Immune Globulin Intravenous Product Overview
10.3.3 CSL Human Immune Globulin Intravenous Product Market Performance
10.3.4 CSL Human Immune Globulin Intravenous SWOT Analysis
10.3.5 CSL Business Overview
10.3.6 CSL Recent Developments
10.4 Octapharma
10.4.1 Octapharma Human Immune Globulin Intravenous Basic Information
10.4.2 Octapharma Human Immune Globulin Intravenous Product Overview
10.4.3 Octapharma Human Immune Globulin Intravenous Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Biotest
10.5.1 Biotest Human Immune Globulin Intravenous Basic Information
10.5.2 Biotest Human Immune Globulin Intravenous Product Overview
10.5.3 Biotest Human Immune Globulin Intravenous Product Market Performance
10.5.4 Biotest Business Overview
10.5.5 Biotest Recent Developments
10.6 Kedrion
10.6.1 Kedrion Human Immune Globulin Intravenous Basic Information
10.6.2 Kedrion Human Immune Globulin Intravenous Product Overview
10.6.3 Kedrion Human Immune Globulin Intravenous Product Market Performance
10.6.4 Kedrion Business Overview
10.6.5 Kedrion Recent Developments
10.7 Hualan Bio
10.7.1 Hualan Bio Human Immune Globulin Intravenous Basic Information
10.7.2 Hualan Bio Human Immune Globulin Intravenous Product Overview
10.7.3 Hualan Bio Human Immune Globulin Intravenous Product Market Performance
10.7.4 Hualan Bio Business Overview
10.7.5 Hualan Bio Recent Developments
10.8 CNBG
10.8.1 CNBG Human Immune Globulin Intravenous Basic Information
10.8.2 CNBG Human Immune Globulin Intravenous Product Overview
10.8.3 CNBG Human Immune Globulin Intravenous Product Market Performance
10.8.4 CNBG Business Overview
10.8.5 CNBG Recent Developments
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Human Immune Globulin Intravenous Basic Information
10.9.2 Shanghai RAAS Human Immune Globulin Intravenous Product Overview
10.9.3 Shanghai RAAS Human Immune Globulin Intravenous Product Market Performance
10.9.4 Shanghai RAAS Business Overview
10.9.5 Shanghai RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Human Immune Globulin Intravenous Basic Information
10.10.2 CBPO Human Immune Globulin Intravenous Product Overview
10.10.3 CBPO Human Immune Globulin Intravenous Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 LFB Group
10.11.1 LFB Group Human Immune Globulin Intravenous Basic Information
10.11.2 LFB Group Human Immune Globulin Intravenous Product Overview
10.11.3 LFB Group Human Immune Globulin Intravenous Product Market Performance
10.11.4 LFB Group Business Overview
10.11.5 LFB Group Recent Developments
10.12 BPL
10.12.1 BPL Human Immune Globulin Intravenous Basic Information
10.12.2 BPL Human Immune Globulin Intravenous Product Overview
10.12.3 BPL Human Immune Globulin Intravenous Product Market Performance
10.12.4 BPL Business Overview
10.12.5 BPL Recent Developments
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information
10.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
10.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Market Performance
10.13.4 Sichuan Yuanda Shuyang Business Overview
10.13.5 Sichuan Yuanda Shuyang Recent Developments
11 Human Immune Globulin Intravenous Market Forecast by Region
11.1 Global Human Immune Globulin Intravenous Market Size Forecast
11.2 Global Human Immune Globulin Intravenous Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Immune Globulin Intravenous Market Size Forecast by Country
11.2.3 Asia Pacific Human Immune Globulin Intravenous Market Size Forecast by Region
11.2.4 South America Human Immune Globulin Intravenous Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Immune Globulin Intravenous by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Human Immune Globulin Intravenous Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Immune Globulin Intravenous by Type (2025-2032)
12.1.2 Global Human Immune Globulin Intravenous Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Immune Globulin Intravenous by Type (2025-2032)
12.2 Global Human Immune Globulin Intravenous Market Forecast by Application (2025-2032)
12.2.1 Global Human Immune Globulin Intravenous Sales (K MT) Forecast by Application
12.2.2 Global Human Immune Globulin Intravenous Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Immune Globulin Intravenous Market Size Comparison by Region (M USD)
Table 5. Global Human Immune Globulin Intravenous Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Human Immune Globulin Intravenous Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2022)
Table 10. Global Market Human Immune Globulin Intravenous Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Human Immune Globulin Intravenous Sales Sites and Area Served
Table 12. Manufacturers Human Immune Globulin Intravenous Product Type
Table 13. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Immune Globulin Intravenous
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Immune Globulin Intravenous Market Challenges
Table 22. Global Human Immune Globulin Intravenous Sales by Type (K MT)
Table 23. Global Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 24. Global Human Immune Globulin Intravenous Sales (K MT) by Type (2019-2025)
Table 25. Global Human Immune Globulin Intravenous Sales Market Share by Type (2019-2025)
Table 26. Global Human Immune Globulin Intravenous Market Size (M USD) by Type (2019-2025)
Table 27. Global Human Immune Globulin Intravenous Market Size Share by Type (2019-2025)
Table 28. Global Human Immune Globulin Intravenous Price (USD/MT) by Type (2019-2025)
Table 29. Global Human Immune Globulin Intravenous Sales (K MT) by Application
Table 30. Global Human Immune Globulin Intravenous Market Size by Application
Table 31. Global Human Immune Globulin Intravenous Sales by Application (2019-2025) & (K MT)
Table 32. Global Human Immune Globulin Intravenous Sales Market Share by Application (2019-2025)
Table 33. Global Human Immune Globulin Intravenous Sales by Application (2019-2025) & (M USD)
Table 34. Global Human Immune Globulin Intravenous Market Share by Application (2019-2025)
Table 35. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2025)
Table 36. Global Human Immune Globulin Intravenous Sales by Region (2019-2025) & (K MT)
Table 37. Global Human Immune Globulin Intravenous Sales Market Share by Region (2019-2025)
Table 38. North America Human Immune Globulin Intravenous Sales by Country (2019-2025) & (K MT)
Table 39. Europe Human Immune Globulin Intravenous Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2019-2025) & (K MT)
Table 41. South America Human Immune Globulin Intravenous Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Human Immune Globulin Intravenous Sales by Region (2019-2025) & (K MT)
Table 43. Global Human Immune Globulin Intravenous Production (K MT) by Region (2019-2025)
Table 44. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2019-2025)
Table 46. Global Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Human Immune Globulin Intravenous Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Takeda Human Immune Globulin Intravenous Basic Information
Table 52. Takeda Human Immune Globulin Intravenous Product Overview
Table 53. Takeda Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Takeda Business Overview
Table 55. Takeda Human Immune Globulin Intravenous SWOT Analysis
Table 56. Takeda Recent Developments
Table 57. Grifols Human Immune Globulin Intravenous Basic Information
Table 58. Grifols Human Immune Globulin Intravenous Product Overview
Table 59. Grifols Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Grifols Business Overview
Table 61. Grifols Human Immune Globulin Intravenous SWOT Analysis
Table 62. Grifols Recent Developments
Table 63. CSL Human Immune Globulin Intravenous Basic Information
Table 64. CSL Human Immune Globulin Intravenous Product Overview
Table 65. CSL Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. CSL Human Immune Globulin Intravenous SWOT Analysis
Table 67. CSL Business Overview
Table 68. CSL Recent Developments
Table 69. Octapharma Human Immune Globulin Intravenous Basic Information
Table 70. Octapharma Human Immune Globulin Intravenous Product Overview
Table 71. Octapharma Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Octapharma Business Overview
Table 73. Octapharma Recent Developments
Table 74. Biotest Human Immune Globulin Intravenous Basic Information
Table 75. Biotest Human Immune Globulin Intravenous Product Overview
Table 76. Biotest Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Biotest Business Overview
Table 78. Biotest Recent Developments
Table 79. Kedrion Human Immune Globulin Intravenous Basic Information
Table 80. Kedrion Human Immune Globulin Intravenous Product Overview
Table 81. Kedrion Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Kedrion Business Overview
Table 83. Kedrion Recent Developments
Table 84. Hualan Bio Human Immune Globulin Intravenous Basic Information
Table 85. Hualan Bio Human Immune Globulin Intravenous Product Overview
Table 86. Hualan Bio Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Hualan Bio Business Overview
Table 88. Hualan Bio Recent Developments
Table 89. CNBG Human Immune Globulin Intravenous Basic Information
Table 90. CNBG Human Immune Globulin Intravenous Product Overview
Table 91. CNBG Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. CNBG Business Overview
Table 93. CNBG Recent Developments
Table 94. Shanghai RAAS Human Immune Globulin Intravenous Basic Information
Table 95. Shanghai RAAS Human Immune Globulin Intravenous Product Overview
Table 96. Shanghai RAAS Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Shanghai RAAS Business Overview
Table 98. Shanghai RAAS Recent Developments
Table 99. CBPO Human Immune Globulin Intravenous Basic Information
Table 100. CBPO Human Immune Globulin Intravenous Product Overview
Table 101. CBPO Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. CBPO Business Overview
Table 103. CBPO Recent Developments
Table 104. LFB Group Human Immune Globulin Intravenous Basic Information
Table 105. LFB Group Human Immune Globulin Intravenous Product Overview
Table 106. LFB Group Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. LFB Group Business Overview
Table 108. LFB Group Recent Developments
Table 109. BPL Human Immune Globulin Intravenous Basic Information
Table 110. BPL Human Immune Globulin Intravenous Product Overview
Table 111. BPL Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. BPL Business Overview
Table 113. BPL Recent Developments
Table 114. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information
Table 115. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
Table 116. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Sichuan Yuanda Shuyang Business Overview
Table 118. Sichuan Yuanda Shuyang Recent Developments
Table 119. Global Human Immune Globulin Intravenous Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Human Immune Globulin Intravenous Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Human Immune Globulin Intravenous Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Human Immune Globulin Intravenous Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Human Immune Globulin Intravenous Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Human Immune Globulin Intravenous Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Human Immune Globulin Intravenous Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Human Immune Globulin Intravenous Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Human Immune Globulin Intravenous Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Human Immune Globulin Intravenous Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Human Immune Globulin Intravenous Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Human Immune Globulin Intravenous Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Human Immune Globulin Intravenous Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Human Immune Globulin Intravenous
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Immune Globulin Intravenous Market Size (M USD), 2019-2032
Figure 5. Global Human Immune Globulin Intravenous Market Size (M USD) (2019-2032)
Figure 6. Global Human Immune Globulin Intravenous Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Immune Globulin Intravenous Market Size by Country (M USD)
Figure 11. Human Immune Globulin Intravenous Sales Share by Manufacturers in 2023
Figure 12. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers in 2023
Figure 13. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Immune Globulin Intravenous Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Immune Globulin Intravenous Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Immune Globulin Intravenous Market Share by Type
Figure 18. Sales Market Share of Human Immune Globulin Intravenous by Type (2019-2025)
Figure 19. Sales Market Share of Human Immune Globulin Intravenous by Type in 2023
Figure 20. Market Size Share of Human Immune Globulin Intravenous by Type (2019-2025)
Figure 21. Market Size Market Share of Human Immune Globulin Intravenous by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Immune Globulin Intravenous Market Share by Application
Figure 24. Global Human Immune Globulin Intravenous Sales Market Share by Application (2019-2025)
Figure 25. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2023
Figure 26. Global Human Immune Globulin Intravenous Market Share by Application (2019-2025)
Figure 27. Global Human Immune Globulin Intravenous Market Share by Application in 2023
Figure 28. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2025)
Figure 29. Global Human Immune Globulin Intravenous Sales Market Share by Region (2019-2025)
Figure 30. North America Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 32. U.S. Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Human Immune Globulin Intravenous Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Human Immune Globulin Intravenous Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 37. Germany Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Human Immune Globulin Intravenous Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 44. China Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Human Immune Globulin Intravenous Sales and Growth Rate (K MT)
Figure 50. South America Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 51. Brazil Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Human Immune Globulin Intravenous Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Human Immune Globulin Intravenous Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Human Immune Globulin Intravenous Production Market Share by Region (2019-2025)
Figure 62. North America Human Immune Globulin Intravenous Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Human Immune Globulin Intravenous Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Human Immune Globulin Intravenous Production (K MT) Growth Rate (2019-2025)
Figure 65. China Human Immune Globulin Intravenous Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Human Immune Globulin Intravenous Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Human Immune Globulin Intravenous Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Immune Globulin Intravenous Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Immune Globulin Intravenous Sales Forecast by Application (2025-2032)
Figure 71. Global Human Immune Globulin Intravenous Market Share Forecast by Application (2025-2032)
